Xing Lin

7PUBLICATIONS
8CO-AUTHORS
Haematological tumoursCardiology (incl. cardiovascular diseases)Molecular targetsPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 21, 2026
POSTN⁺ CAF-SPP1⁺ macrophage crosstalk is associated with immune exclusion and poor prognosis in lung adenocarcinoma.

|Jun 11, 2026
Development and external validation of a machine learning model for cardiovascular risk prediction in individuals with chronic lung disease: Evidence from CHARLS and ELSA.

|May 01, 2023
TRIM9 Interacts with ZEB1 to Suppress Esophageal Cancer by Promoting ZEB1 Protein Degradation via the UPP Pathway.

Zhaoxian Lin, Jianyuan Huang, Lihuan Zhu

|May 02, 2022
Mxi1 participates in the progression of lung cancer via the microRNA-300/KLF9/GADD34 Axis.

Yujie Lei, Yunchao Huang, Jianbin Lin

|Jan 13, 2022
Indocyanine green fluorescence imaging improves the assessment of blood supply of interposition jejunum.

Zhaoxian Lin, Shihui Sun, Yangming Chen

|Oct 29, 2020
The LINC01260 Functions as a Tumor Suppressor via the miR-562/CYLD/NF-κB Pathway in Non-Small Cell Lung Cancer.

Yangming Chen, Yujie Lei, Jianbin Lin

Pageof 2

Frequent Collaborators

1 joint publications

Zhaoxian Lin

1 joint publications

Jianyuan Huang

1 joint publications

Lihuan Zhu

1 joint publications

Yangyun Huang